Sumitomo Pharma America

Sumitomo Pharma America is owned by Sumitomo Chemical.

Sumitomo Chemical is one of the...

• Forbes Global 2000 (#1009);
• Nikkei 225;
• Topix.

Sumitomo Chemical is a company listed under the stock ticker 4005 (JP).

Sumitomo Chemical has a direct presence in 6 countries.

Sumitomo Chemical has 28 subsidiaries including Asahi Chemical, Ciox Health and Covant Therapeutics.

They are in:

• Biotechnology55%
• Chemicals24%
• Other21%

View the org chart displaying its 30 main executives

Most searched biographies at Sumitomo Pharma America

• Myrtle Potter, Chief Executive Officer
• Tsutomu Nakagawa, Chief Strategy Officer
• Armin Szegedi, Chief Medical Officer

Create your alert
to follow the executive moves at Sumitomo Pharma America.

Sumitomo Chemical has 2,282 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Sumitomo Pharma America

• Sumitomo Pharma America Newsroom - News ReleasesBack ButtonFilter Button
• News | Sumitovant

Social media about Sumitomo Pharma America

• Sumitomo Pharma America on Wikipedia, Google News & Yahoo Finance
• Sumitomo Pharma America on LinkedIn, Twitter & YouTube

Contact by email its executives including Myrtle Potter

Call Sumitomo Pharma America at +1 646...

View the org chart

Register to receive your alert

Report an error